Abbonarsi

Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure - 05/08/11

Doi : 10.1016/j.ahj.2010.08.004 
Rebecca S. Boxer, MD a, , Anne M. Kenny, MD b, Vinay K. Cheruvu, MSc, MS c, Marianne Vest, MA, BSN, RN a, Justin J. Fiutem, MS, RCEP d, Ileana I. Piña, MD, MPH a
a Department of Medicine, Case Western Reserve University, Cleveland, OH 
b Center on Aging, Department of Medicine, University of Connecticut Health Center, Farmington, CT 
c Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH 
d Department of Pediatrics, Case Western Reserve University, Cleveland, OH 

Reprint requests: Rebecca Sue Boxer, MD, Harrington McLaughlin Heart and Vascular Institute, University Hospitals/Case Medical Center, 11100 Euclid Ave, Cleveland, OH 44106.

Riassunto

Background

Vitamin D is a fat-soluble hormone necessary for calcium homeostasis. Recently, studies have demonstrated that vitamin D may be important to the health of the cardiovascular system.

Methods

Adults ≥50 years of age with heart failure were recruited for assessment of serum 25-hydroxyvitamin D (25OHD) concentrations. Cardiopulmonary exercise testing was used to assess functional capacity. Proximal muscle strength was evaluated with a Biodex leg press (Biodex, Shirley, NY), and health status was assessed with the Kansas City Cardiomyopathy Questionnaire. Univariate associations between physical performance and health status measures and 25OHD followed by a linear regression model were used to study associations, adjusting for other potential explanatory variables.

Results

Forty adults 67.8 ± 10.9 years of age (55% women and 57.5% African American) with mean ejection fraction 40% were analyzed (New York Heart Association class II in 70% and class III in 30%). Comorbidities included 77.5% hypertension and 47.5% diabetes. The mean 25OHD concentration was 18.5 ± 9.1 ng/mL, and mean peak Vo2, 14 ± 4 mL/kg/min. In univariate regression analysis, 25OHD was positively associated with peak Vo2 (P = .045). Multivariable regression analysis sustained positive association between 25OHD and peak Vo2 (P = .044) after adjusting for age, race, and respiratory exchange ratio (adjusted R2 = 0.32). Association between proximal muscle strength with the 25OHD concentration was not significant. The Kansas City Cardiomyopathy Questionnaire physical limitation domain score was negatively associated with 25OHD (P = .04) but was not sustained in multivariable analysis.

Conclusions

25-Hydroxyvitamin D may be an important marker or modulator of functional capacity in patients with heart failure. Randomized controlled trials are needed to assess the effect of vitamin D repletion on functional performance.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2010  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 160 - N° 5

P. 893-899 - novembre 2010 Ritorno al numero
Articolo precedente Articolo precedente
  • Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries
  • Robb D. Kociol, Bradley G. Hammill, Gregg C. Fonarow, Winslow Klaskala, Roger M. Mills, Adrian F. Hernandez, Lesley H. Curtis
| Articolo seguente Articolo seguente
  • Cardiopulmonary exercise testing characteristics in heart failure patients with and without concomitant chronic obstructive pulmonary disease
  • Marco Guazzi, Jonathan Myers, Marco Vicenzi, Daniel Bensimhon, Paul Chase, Sherry Pinkstaff, Ross Arena

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.